Abstract
Among the candidate eye muscle autoantigens proposed as being relevant to the pathogenesis of thyroid-associated ophthalmopathy (TAO), a 64 kDa membrane autoantigen appears to be most closely associated with the eye disorder. We have examined the tissue localization and some of the physicochemical properties of this molecule in 3 human tissues, namely thyroid (THY), eye muscle (EM) and skeletal muscle (SKE), and in pig eye muscle (PEM), by two-dimensional (2-D) [isoelectric focusing (IEF)/sodium dodecyl Polyacrylamide gel electrophoresis (SDS-PAGE)] gel electrophoresis followed by Western blotting. Antibody probes used were whole sera from patients with TAO and antibodies affinity purified from TAO sera by binding to, and elution from, a sepharose-4B column conjugated with D1, a 98 amino acid peptide fragment of a recombinant 64 kDa thyroid autoantigen. Soluble membrane proteins eluted from a slice of SDSPAGE gel containing 60–70 kDa material was prepared from the four tissues and used as antigen for 2-D gel separation. The presence of a 64 kDa antigen in THY and EM recognized by sera from patients with TAO, but only rarely by those from normal individuals, was confirmed. Pretreatment of the eluted 60–70 kDa material with N-Glycosidase F to eliminate charge heterogeneity resulting from glycosylation differences, changed the pl and MW of molecules recognized by TAO sera, in THY and EM. This suggests that the 64 kDa molecule(s) in EM and THY targeted by sera from patients with TAO are glycoproteins and that they are different in the two tissues. On the other hand, the molecule recognized in SKE appeared to have a different MW, perhaps representing the 66 kDa protein identified in previous immunoprecipitation studies, while that recognized in PEM closely resembled the molecule identified in EM and THY, but with a more basic pl range.
Similar content being viewed by others
References
Weetman A.P., Cohen S., Gatter K.C., Fells P., Shine B. Immunohistochemical analysis of the retrobulbar tissues in Graves’ ophthalmopathy. Clin. Exp. Immunol. 75: 222, 1989.
Tallstedt L., Norberg R. Immunohistochemical staining of normal and Graves’ extraocular muscle. Invest. Ophthal. Vis. Sci 29: 175, 1988.
Bahn R.S., Gorman C.A., Johnson C.M., Smith T.J. Presence of antibodies in the sera of patients with Graves’ disease recognizing a 23 kDa fibroblast protein. J. Clin. Endocrinol. Metab. 69: 622, 1989.
Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in serum of patients with thyroid-associated ophthalmopathy. FEBS Lett 232: 135, 1988.
Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J.R. Demonstration of a circulating autoantibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet 2: 1353, 1982.
Salvi M., Bernard N., Miller A., Zhang Z.G., Gardini E., Wall J.R. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid 7: 207, 1991.
Ahmann A., Baker J.R., Weetman A.P., Wartofsky L, Nutmann T.B., Burman K.D. Antibodies to porcine eye muscle in patients with Graves’ ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay. Endocrinol. Metab. 64: 454, 1987.
Weetman A.P., Fells P., Shine B. T and B cell reactivity to extraocular and skeletal muscle in Graves’ ophthalmopathy. Br. J. Ophthalmol. 7: 323, 1989.
Hiromatsu Y., Fukazawa H., Guinard F., Salvi M., How J., Wall J.R. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 67: 565, 1988.
Wall J.R., Salvi M., Bernard N.F., Boucher A., Haegert D. Thyroid-associated ophthalmopathy — a model for the association of organ-specific autoimmune disorders. Immunol. Today 12: 150, 1991.
Zhang Z.G., Salvi M., Miller A., Bernard N., Arthurs B., Wall J.R. Restricted tissue reactivity of autoantibodies to a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Clin. Immunol. Immunopathol. 62: 183, 1992.
Dong Q., Ludgate M., Vassart G. Cloning and sequencing of a novel 64 kDa autoantigen recognized by patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 72: 1375, 1991.
Hochstrasser D.F., Harrington M.G., Hochstrasser A.C., Miller M.J., Merril C.R. Methods for increasing the resolution of two-dimensional protein electrophoresis. Anal. Biochem. 173: 424, 1988.
Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970: 227, 680.
Gérard C. Purification of glycoproteins. In: Deutscher M.P. (Ed.), Methods in Enzymology. Academic Press, Inc., NY., 1990, vol. 182, p. 529.
Boucher A., Bernard N., Miller A., Salvi M., Wall J.R. Sera from patients with thyroid-associated ophthalmopathy recognize the same 64 kDa antigen in eye muscle and thyroid in two-dimensional gel electrophoresis. Thyroid 1(Suppl. 1): 5–22, 1991 (Abstract).
Foti D., Rapoport B. Carbohydrate moieties in recombinant human thyroid peroxidase: role in recognition by antithyroid peroxidase antibodies in Hashimoto’s thyroiditis. Endocrinology 726: 2983, 1990.
Miller A., Arthurs S., Boucher A., Liberman A., Bernard N., Salvi M., Wall J.R. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity. Thyroid 2: 197, 1992.
Kendler D.L., Rootman J., Huber G.K., Davies T.F. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves’ thyroid and ophthalmic diseases. Clin. Endocrinol. (Oxf.) 35: 539, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boucher, A., Bernard, N., Miller, A. et al. Two dimensional gel electrophoresis identifies minor differences in immunologically cross-reactive 64 KDA autoantigens in the thyroid and eye muscle. J Endocrinol Invest 17, 7–13 (1994). https://doi.org/10.1007/BF03344954
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344954